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Genome-wide association meta-analysis of corneal
curvature identifies novel loci and shared genetic
influences across axial length and refractive error
Qiao Fan et al.#
Corneal curvature, a highly heritable trait, is a key clinical endophenotype for myopia - a
major cause of visual impairment and blindness in the world. Here we present a trans-ethnic
meta-analysis of corneal curvature GWAS in 44,042 individuals of Caucasian and Asian with
replication in 88,218 UK Biobank data. We identified 47 loci (of which 26 are novel), with
population-specific signals as well as shared signals across ethnicities. Some identified
variants showed precise scaling in corneal curvature and eye elongation (i.e. axial length) to
maintain eyes in emmetropia (i.e. HDAC11/FBLN2 rs2630445, RBP3 rs11204213); others
exhibited association with myopia with little pleiotropic effects on eye elongation. Implicated
genes are involved in extracellular matrix organization, developmental process for body and
eye, connective tissue cartilage and glycosylation protein activities. Our study provides
insights into population-specific novel genes for corneal curvature, and their pleiotropic effect
in regulating eye size or conferring susceptibility to myopia.
https://doi.org/10.1038/s42003-020-0802-y OPEN
#A full list of authors and their affiliations appears at the end of the paper.
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Refractive error is common worldwide and particularly so inAsia, where uncorrected refractive error is one of the majorcauses of visual impairment and blindness1,2. In 2015,
uncorrected refractive error caused moderate or severe visual
impairment in 116 million people, and blindness in 7.4 million
people—these figures are expected to rise to 128 million and
8.0 million, respectively, by 20203. Thus there is a critical need to
better understand the genetic basis of how different optical
components may contribute to ammetropia, for which corneal
curvature represents a main endophenotype.
Corneal curvature (CC) is a key clinical endophenotype for the
refractive status of the eye. The corneal air-tissue interface pro-
vides approximately two-thirds of the eye’s optical power4. Thus,
changes in the CC significantly affect refractive error, such as
myopia. A steeper CC was associated with a more negative/
myopic refractive error. In the emmetropic eye, the refractive
power of the eye’s optical components (such as CC) must be
appropriate to its axial length (AL). If the changes in CC, AL,
or other ocular components such as lens thickness or anterior
chamber depth are not aligned, refractive errors (myopia or
hyperopia) are likely to occur.
Clinically, CC associates with ethnicity5,6, age7, and anthro-
pometric features (height and weight)7. Based on family and twin
studies, CC is highly heritable, with 35–95% of inter-individual
CC variation attributed to genetic factors8–12. Previous genome-
wide association studies (GWASs) have been successful in iden-
tifying more than 160 loci associated with refractive error13–15,
and nine loci associated with AL16. Only four loci associated
with CC have been previously reported from GWAS analyses:
MTOR17, CMPK118, and RBP318 identified in Asians, and
PDGFRA in both Asians17 and Europeans11,19. A further 31 loci
in European emmetropes, accounting for an additional 2.3% of
variance in CC, have also been provisionally reported20. Asso-
ciated variants identified to date cannot fully explain the additive
genetic variance of CC, and hence other genetic variants are likely
to contribute to this endophenotype. The difference in the pre-
valence of myopia in various ethnic groups, particularly in
Asia, also suggests that certain CC-associated alleles may be
population-specific11. Furthermore, the extent to which shared or
distinct genetic loci contribute to variation in CC, AL, and
spherical equivalent is uncertain.
Thus, we conducted the largest GWAS meta-analysis of CC to
date, incorporating both European and Asian cohorts in a single
analysis from the Consortium for Refractive Error and Myopia
(CREAM) and validated our findings in the United Kingdom
(UK) Biobank.
Results
Primary GWAS of corneal curvature. The CREAM discovery
cohorts included 29,580 individuals with European ancestry from
18 studies, and 14,462 individuals with Asian ancestry from
10 studies. The demographics of these 44,042 participants are
shown in Supplementary Table 1. GWAS analyses for CC were
performed at the cohort level for all variants genotyped or
imputed using the 1000 Genomes Project data as reference
panels7 (Supplementary Table 2). The genomic control inflation
factor (λGC: 0.872–1.085) showed little evidence of inflation in test
statistics at the study level.
We applied a uniform set of quality-control procedures to all
cohort-level GWAS results in CREAM and meta-analysed up to
8.94 million variants (see Methods). For the discovery phase, we
performed an inverse-variance-weighted meta-analysis on the
European and Asian populations. The quantile-quantile plot for
the trans-ethnic meta-analysis (λGC: 1.119; Supplementary Fig. 1)
indicated moderate inflation, and genomic control-adjusted test
statistics were generated. The inflation is partially due to
polygenicity as the linkage disequilibrium (LD)-score regression
intercepts were close to one21 (LD-score regression intercept of
1.045 in Europeans and 1.013 in Asians).
Figure 1 shows the Manhattan plot for the trans-ethnic meta-
analysis for CC. We identified 41 loci at genome-wide significance
(P < 5.0 × 10−8; Table 1; Supplementary Figs. 2–4). We per-
formed replication analyses of these loci for CC in 88,218
participants with European ancestry from the UK Biobank.
Thirty-seven (90.2%) of the 41 lead variants passed genome-wide
significance in the UK Biobank data (Table 1). The signals of the
two loci (CMPK1/STIL, RBP3) not reaching genome-wide
significance in the replication phase were mainly driven by the
CREAM Asian populations. In the combined CREAM and UK
Biobank meta-analysis, the five most strongly associated loci were
RSPO1 (rs4074961; P= 6.51 × 10−100), HUS1 (rs12702376; P=
2.77 × 10−86), FGF9 (rs9506725; P= 1.21 × 10−78), PDGFRA
RSPO1
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Fig. 1 Manhattan plot of trans-ethnic GWAS meta-analysis for corneal curvature. Both directly genotyped and imputed variants were meta-analysed for
corneal curvature in 44,042 CREAM participants. The y-axis represents −log10p values for association with corneal curvature, and the x-axis represents
genomic position based on human genome build 37, highlighting newly identified loci (arrows in blue; Table 1), loci associated with axial length (labelled
with nearest gene names), and loci associated with spherical equivalent (cross in green). The horizontal red line indicates the genome-wide significance
level of P < 5.0 × 10−8. The horizontal blue line indicates the suggestive significance level of P < 1.0 × 10−5.
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(rs1800813; P= 1.59 × 10−73), and HDAC11/FBLN2 (rs2630445;
P= 4.92 × 10−67). The RSPO1 gene was previously identified as
the strongest locus with the same lead SNP rs4074961 associated
with AL in CREAM16. Here it stands out as the most significant
locus for CC in our large meta-analysis. We confirmed
associations with CC in the four previously identified loci in
our samples: PDGFRA, MTOR, RBP3, and CMPK111,17–19, and
in an additional 17 loci provisionally identified in the European
emmetropes from the UK Biobank20. In total, we identified
20 novel CC loci through single-variant analysis.
Following the age classification scheme adopted by the
CREAM consortium, we stratified the CREAM samples into
younger (age < 25 years) and older (age ≥ 25 years) groups. In the
older group (n= 35,442), the top five genome-wide significant
loci were RSPO1, MTOR, PDGFRA1, HUS1, and FGF9 (Supple-
mentary Data 1). There were no novel genome-wide significant
hits for CC in both groups. No variants reached genome-wide
significance in the younger group (n= 8620), likely due to the
insufficient power in contrast to the older group. The effect sizes
and directions of effect for the top variants were consistent
between the younger and older groups.
Trans-ethnic comparison of genotypic effects in Europeans
versus Asians. Among the 41 lead variants identified in the full
discovery samples, the effect size and direction of effect were
largely consistent across Europeans and Asians (Table 1). To
evaluate whether genetic effect sizes were consistent in Europeans
versus Asians in the CREAM samples, we compared additive
effect sizes (beta coefficient in millimetre per allele) of variants
with p-value < 0.01 in both populations. We grouped these var-
iants by inter-population allele frequency discrepancy between
the two ancestry groups (<0.1, 0.1–0.3, and >0.3). Overall, the
variants were concordant in direction of effects and effect sizes
(Fig. 2a–c). The effect sizes appeared most consistent in variants
with little discrepancy in allele frequency (2a; allele frequency
difference < 0.1), and less consistent in variants of larger allele
frequency discrepancy (2c; allele frequency difference > 0.3).
The high concordance of genetic effects between Europeans
and Asians, however, could not rule out the possibility
of discrepancy at some loci with large inter-population
differences in the allele frequency and LD structure. Three loci
in our all-ancestry analyses were driven by European populations
(HDAC11/FBLN2 rs2630445, ADAMTS19/CASY3 rs7708378, and
Fig. 2 Concordance of effect sizes of variants between European and Asian populations and loci showing population-specific signals. a–c For each
scatter plot, effect size in Asians (x-axis) and in Europeans (y-axis) was plotted for variants with P < 0.01 in both ancestry groups in CREAM. The variants
were grouped based on the allele frequency difference between European and Asian populations: a <0.1; b 0.1–0.3, and d >0.3. The red dot represents
variants with P < 1.0 × 10−7 in the meta-analysis of combined population, and green circle indicates variant with 1.0 × 10−7 < P < 0.01 in both Europeans and
Asians. Dashed line in red is the fitted line and in grey is the x= y line of unity. d–i Regional plots in CREAM Europeans (d–f) and Asians (g–i) showing
population-specific signals at loci exhibiting allele frequency differences: HDAC11/FBLN2 (d, g), CMPK1/STIL (e, h) and c FGF9 (f, i). Here we present
regional plots for three lead variants. (i) Lead variant rs2630445 in plot d showing genome-wide association signals in Europeans (MAF= 0.10) is
monomorphic in Asian populations. (ii) Lead variant rs60078183 in plot h exhibiting association in Asians (MAF= 0.21) is monomorphic in European
populations. (iii) Lead variant rs9506725 in plot f showing association in Europeans (MAF= 0.36) is monomorphic in Asian populations.
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FGF9 rs9506725), and two loci were driven by Asian populations
(RBP3 rs11204213 and CMPK1/STIL rs60078183). In the ethnic
group (either the Asian or European populations) where these
variants were not associated, they typically presented as
monomorphic in the other ethnic group, as well as those variants
in LD with the lead variant (r2 ≥ 0.8; Supplementary Data 2).
Regional plots at HDAC11/FBLN2 rs2630445, CMPK1/STIL
rs60078183, and FGF9 rs9506725 were presented in Europeans
(Fig. 2d–f) and Asians (Fig. 2g–i), respectively, with inter-
population allele frequency at 0.10, 0.20, and 0.36. The proxy
SNPs adjacent showed minimal significance at only two loci in
Asians (HDAC11/FBLN2 rs2655225, P= 3.34 × 10−3, r2= 0.62)
and ADAMTS19/CASY3 rs11746536; P= 2.67 × 10−4, r2= 0.11;
Supplementary Table 3). For GWAS analyses performed
separately in Europeans and Asians, there were two Asian-
specific loci (EMX2/EMX2OS rs2240776, P= 2.45 × 10−8;
NCAPG rs7672919, P= 3.90 × 10−8; Supplementary Table 4);
both did not reach genome-wide significance in the combined
analysis. In addition, one locus showing suggestive significance in
CREAM Europeans (PIEZO2 rs2101976; P= 7.32 × 10−8) has
been replicated in the UK Biobank data (P= 8.90 × 10−14).
We calculated SNP-heritability (SNP-h2) using GWAS summary
statistics22. The SNP-h2 estimate for CC in Asians (0.196, s.e.=
0.036) was numerically lower than in Europeans (0.267, s.e.=
0.024), but there was no statistical evidence for a meaningful
difference. A similar pattern was noted in a previous study12.
Association of corneal curvature loci with spherical equivalent
and axial length. In further analyses, we assessed the associations
of the 41 CC lead variants with spherical equivalent14,15 in 95,505
participants from the UK Biobank, as well as in a subset of
CREAM participants with AL measurement (N= 10,851; Sup-
plementary Table 5). The lead variants were categorized into the
following three groups using false discovery rates (FDR) set at a
threshold of 1% from the Benjamini-Hochberg procedure23
(Fig. 3 and Supplementary Data 3).
Eight CC variants were associated with AL, but not spherical
equivalent (Group A, Fig. 3). That is, the effect allele of the
variant was associated with eye size, e.g. a larger eye with both a
flatter CC and longer AL (positive genetic effects on both CC and
AL; bar in red, Fig. 3) or a smaller eye with both a steeper CC and
shorter AL (negative genetic effects; bar in blue), but was not
associated with spherical equivalent. For instance, HMGA2
rs7959830 T allele was associated with a steeper CC (β=
−0.018, s.e.= 0.002, P= 3.02 × 10−16) and shorter AL (β=
−0.047, s.e.= 0.014, P= 6.54 × 10−4), but not spherical equiva-
lent (β= 0.005, s.e.= 0.013, P= 0.670). A lack of association with
refractive error at these variants might be explained on the basis
of the compensatory effects resulting in, a steeper CC (that tends
to make the eye more myopic) and shorter AL (that tends to
make the eye more hyperopic/less myopic), or a flatter CC and
longer AL The compensatory genetic effects for CC and AL
relevant to the effects on myopia or hyperopia is illustrated in
Fig. 4. Among these variants, the pleiotropic association on AL of
HDAC11/FBLN2 rs2630445, ADAMTS19/CHSY rs7708378 were
mainly driven from European populations, and RBP3 rs11204213
from Asian populations.
Fifteen CC variants were associated with spherical equivalent
(Group B, Fig. 3). Eleven of these variants were not associated
with AL. The strongest signals associated with spherical
equivalent (P < 1 × 10−7) were CASC15 rs9366426, CHRND/
PRSS56 rs2245601, KAZALD1 rs807037, FBN1 rs9806595, and
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Fig. 3 Effect sizes on cornea curvature, axial length and spherical equivalent for CC-associated variants. Corneal curvature (CC)-associated genetic
variants identified from CREAM (n= 44,042) were grouped based on the patterns of the associations of effect alleles with axial length (AL; n= 10,851)
and spherical equivalent (n= 95,505). Group A—variants associated with AL only (‘eye-size’ determining genetic variants); the effect allele of each variant
was associated with eye size: a larger eye with both a flatter CC and longer AL (positive β on both CC and AL; bar in red), and a smaller eye with both a
steeper CC and shorter AL (negative β; bar in blue). These variants were not associated with spherical equivalent. Group B—variants associated with
spherical equivalent; the allele associated with a steeper CC was associated with a more negative refractive error (or vice versa). These variants were not
associated with AL, except those at loci IGFBP5/TNP1, HUS1, RP11-91P17.1, and FGF9. Group C—variants not associated with spherical equivalent or AL. For
the associations with axial length and spherical equivalent, FDR < 0.01 was considered significance. The colour of the bar represents a positive genetic
effect (in red) or a negative genetic effect (in blue).
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RNLS rs166976. Among these 11 variants, the allele associated
with a steeper CC was associated with a more negative/myopic
refractive error (or a flatter CC and more positive/hyperopic
refractive error). For instance, FBN1 rs9806595 T allele was
associated with a steeper CC (β=−0.012, s.e.= 0.002, P= 2.23 ×
10−8) and more myopic refractive error (β=−0.084, s.e.= 0.014,
P= 1.40 × 10−8), but not AL (β=−0.015, s.e= 0.013, P= 0.231).
For the remaining CC variants at four loci that were associated
spherical equivalent as well as AL (HUS1, RP11-91P17.1, FGF9,
and IGFBP5/TNP1), the direction of genetic effect on spherical
equivalent may depend on the relative magnitude of effect on CC
versus AL. For instance, although both HUS1 rs12702376 C allele
and RP11-91P17.1 rs7004112 T allele were associated with steeper
CC (that tends to make the eye more myopic) and shorter AL
(that tends to make the eye less myopic), HUS1 was associated
with a negative/myopic refractive error, while RP11-91P17.1 was
associated with a positive/hyperopic refractive error. Among
these variants, pleiotropic effects of FGF9 rs9506725 were mainly
driven from European populations.
The remaining 18 CC variants (Group C, Fig. 3) were not
associated with spherical equivalent or AL at FDR > 1%. The
association on CC and spherical equivalent at the majority loci
was, although not significant, in an expected direction, e.g. with a
steeper CC and a more negative/myopic refractive error (or vice
versa). Among these variants, CMPK1/STIL rs60078183 was
mainly driven by Asian populations. The pleiotropic genetic
effects on spherical equivalent of CC-associated variants, together
with previously implicated AL variants16,24, are summarized in
Supplementary Fig. 5.
The pleiotropic effect ratio βALβCC was meta-analyzed across all
variants in each group (Fig. 4; Supplementary Table 6). The
pleiotropic ratio βALβCC in group A (2.92, 95% CI: 2.37–3.48) was
larger than that in group B (1.66, 95% CI: 1.16–2.16) and C (1.19,
95% CI: 0.78–1.61), with p-value at 7.56 × 10−4 and 1.68 × 10−6,
respectively. For variants in group A, the pleiotropic effect for AL
could offset genetic effect for CC towards myopia or hyperopia;
namely, a genetically determined 1 mm increase (or decrease) for
CC accompanied by a 2.92 mm increase (or decrease) on average
for AL might cancel out their respective opposite effects on
refractive error. In contrast, if the pleiotropic effects on AL could
not compensate effects on CC, as shown in Group B, these
variants may influence refractive error primarily through the net
effect of CC. The interplay between AL, CC and refractive error at
the variants in Group C is less clear, likely these variants might
have pleiotropic effect for other endophenotypes, besides AL, to
account for the genetic effects of CC on refractive error.
Post GWAS gene-based and pathway analyses. We applied
gene-based tests using the Versatile Gene-based Association
Study (VEGAS)25,26, with Bonferroni corrected p-value at 2.09 ×
10−6 to test 24,000 genes for significance. Over and above the loci
found in the per-variant tests, six additional genomic regions
were significantly associated with CC via gene-based tests (Sup-
plementary Table 7): ANKRD65 (P= 9.0 × 10−7), PEAR1 (P=
1.57 × 10−7), ASB1 (P= 2.54 × 10−7), GMDS (P= 2.48 × 10−8),
EMX2OS (P= 4.84 × 10−8), and HM13-AS1 (P= 2.18 × 10−7).
We further conducted gene-set analysis using VEGAS by testing
whether CC genes shared a common function or operated in the
same pathways (see Methods). Thirty pathways were identified at
Bonferroni corrected p-value of 5.14 × 10−6 (Supplementary
Data 4), with those involving proteinaceous extracellular matrix
(ECM) (GO: 0005578; P= 1.05 × 10−9) and ECM (GO: 0031012,
P= 7.53 × 10−9) being the top two. The other significant pathways
included gene sets involved in eye development (GO:0001654; P=
4.00 × 10−7) and camera-type eye development, GO: 0043010, P=
3.20 × 10−6), as well as those involving in organ morphogenesis
(GO:0009887; P= 4.86 × 10−7), skeletal system development
(GO:0001501; P= 5.25 × 10−7) and the Wnt signalling pathway
(KEGG:04310, P= 2.09 × 10−6). For the top 41 loci identified in
this study plus genes previously reported for CC (WNT7B24
and ZNRF316), we conducted gene-set analysis using g: Profiler
(https://biit.cs.ut.ee/gprofiler/gost) and identified 48 significant
pathways at multiple testing corrected p-value of 0.05. Among
these, collagen-containing ECM (GO: 0062023; P= 2.72 × 10−7)
and ECM (GO: 0031012; P= 6.51 × 10−6) were the most significant
terms (Supplementary Data 5). Other significant pathways
consisted of heparin binding (GO: 0062023; P= 6.95 × 10−5),
embryonic morphogenesis (GO: 0048598; P= 3.99 × 10−4), glyco-
saminoglycan binding (GO: 0005539, P= 6.86 × 10−4), and skeletal
system development (GO: 0001501; P= 1.11 × 10−3) etc.
To visualize functional enrichment of identified gene-sets, we
mapped these sets graphically into an enrichment network27 in
Cytoscape28. Similarity coefficients greater than 0.375 were used
to place these sets together with the interconnectivity drawn by a
line. Using comprehensive collections of gene-sets related to CC,
we identified enrichments in gene-sets involved in organism
development and growth, with components for eye development
and connective tissue cartilage, explicitly suggesting a strong
genetic link between the size of the eye and organism/body
(Fig. 5). We also observed that gene-sets were involved in ECM
and glycosylation protein activity, which have previously been
suggested in pathways related to central corneal thickness29.
To assess any specific roles of subset of CC genes with
pleiotropic effects on myopia, we performed gene-set clustering.
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Fig. 4 Illustration of pleiotropic effect ratio βALβCC and effects toward
emmetropic and myopic states. The figure illustrates genetic effects of AL
(βAL) might or might not compensate genetic effects of corneal curvature
(βCC) toward myopia or hyperopia. Longer CC (shown by positive βCC;
arrow upward) tends to make the eye hyperopic (dashed line in blue) and
longer AL (positive βCC; arrow downward) tends to make the eye more
myopic (dashed line in red). Similarly, steeper CC (negative βCC, arrow
downward) tends to make the eye more myopic and shorter AL (negative
βCC; arrow downward) tends to make the eye less myopic. The
compensatory pleiotropic effects βAL could offset βCC on myopia or
hyperopia at the pleiotropic ratio βALβCC ~ 3, as shown in group A. The
compensatory pleiotropic effects βAL, however, cannot offset βCC on
myopia or hyperopia at smaller pleiotropic ratio βALβCC, as shown in group B.
There might be other pleiotropic effect in Group C, besides AL, to
compensate genetic effect of CC on myopia. Het-I2, for heterogeneous
effects between the variants. All P-value for heterogeneity was >0.05.
Pleiotropic effect ratio was calculated at each variant and combined to
estimate βALβCC and heterogeneity using the meta-analysis approach (see
Methods). Grouping of A, B, and C was the same as in Fig. 3.
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-0802-y
6 COMMUNICATIONS BIOLOGY |           (2020) 3:133 | https://doi.org/10.1038/s42003-020-0802-y | www.nature.com/commsbio
Enriched pathways identified included basement membrane,
endoplasmic reticulum lumen, collagen-containing extracellular
matrix, ossification, and osteoblast differentiation (Fig. 5; Diamond
node; Supplementary Data 5). The pathways were closely
connected to ECM or developmental process, thus underlying a
functional heterogeneity in genes exhibiting pleiotropic effects on
both CC and refractive error.
Additional pathways identified from the whole-genome data
using VEGAS, such as elastic fibre formation, camera-type eye
development and O-linked Glycosylation, also displayed con-
nectivity to the ECM, development processes and glycosylation
protein activity (Fig. 5; nodes in green). A few pathways
(regulation of stem cell differentiation, system development,
etc.) failed to link to any existing gene-sets were identified; this is
likely attributable to marginal and uncharacterized CC-genes.
Biological function of the CC-associated loci. We examined
gene expression in 20 normal human donor eyes from the ocular
tissue database (OTDB; https://genome.uiowa.edu/otdb/). The
majority of the genes identified at the 41 loci were expressed in
human ocular tissues including cornea, sclera, ciliary body, or
lens etc. (Supplementary Data 6). THBS4 had the highest
expression in the cornea and sclera, IGFBP5 in the ciliary body
and sclera, and PDGFRA in the lens.
We also queried expression quantitative trait loci (e-QTL)
database to assess the association between the gene expression and
the top CC-variants in different human tissues (see UTLs).
Twenty-one index variants were eQTLs for the expression of
genes, which resided in, or were adjacent to, the variant
(Supplementary Data 7). Among them, the majority of variants
were eQTL’s for the expression of the nearest gene. There are some
exceptions. For example, SNP rs807037 is a missense variant
within the KAZALD1 gene and is also an eQTL for the nearby gene
SFXN3 in artery, brain, adipose subcutaneous and nerve tissues
(P < 2.20 × 10−5). Intronic MTOR rs3737611 is an eQTL for
EXOSC10 in thyroid, nerve and artery tissues (P < 5.70 × 10−5).
Intronic RSPO1 rs4074961 is an eQTL for itself and nearby genes
GNL2, DNALI1 and MEAF6 in various tissues.
The newly identified genes are largely involved in ocular
growth/development. LMX1B (encoding a LIM homeodomain
class transcription factor) regulates anterior segment morphogen-
esis and patterning30, and is associated with Nail-Patella
syndrome31. Recently, LMX1B has been reported to be associated
with primary open-angle glaucoma, accompanied by development
defects of the ocular anterior segments including cornea32–34.
SOX2 (encoding a member of the SRY-related HMG-box family of
transcription factors) links to both anophthalmia and micro-
phthalmia35. Other CC genes that are also associated with eye or
overall morphology include GHSR (associated with craniofacial
development36), HMGA2 (linked to body height), and LCORL
(linked to skeletal trunk height37).
Five of the implicated genes (ADAMTS3, ADAMTS6,
ADAMTS7, ADAMTS19, and ADAMTS20) belong to the ADAMTS
protein family, which is closely involved in regulating the
organization and function of ECM38. For instance, ADAMTS6
has a major role in focal adhesion and tight junction formation, and
can alter the deposition of fibrillin microfibrils in epithelial cells39.
Interestingly, ADAMTS family members also associate with
height variation (ADAM28, ADAMTS19, ADAMTS2, ADAMTS3,
ADAMTS6, ADAMTSL1, ADAMTSL3), suggesting their pleiotropic
roles in body growth40.
A cluster of novel genes are involved in both ECM and
organism/eye development. For instance, FBN1 encodes the
Eye development
Organism development & growth 
Connective tissue cartilage
Extracellular matrix
Glycosylation protein activity
Fig. 5 Gene-set enrichment analysis for corneal curvature in CREAM data. Enrichment results were mapped as a network of gene-sets (nodes) related by
mutual overlap (edges). Node size is proportional to the total number of genes in each set, colour gradient represents the enrichment significance and edge
thickness represents the number of overlapping genes between sets. Nodes in red represent gene-sets identified from the g:Profiler enrichment analysis,
and in green represent additional gene-sets identified from the VEGAS-pathway analysis. Nodes of diamond show the pathways for the implicated genes
associated with both CC and spherical equivalent (Group 2 in Fig. 3). Groups of functionally related gene-sets are circled and labelled (dashed line).
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ECM protein fibulin-1, which modulates corneal cell migration
by interactions with other ECM components, such as fibronec-
tin41. Weill-Marchesani syndrome (that may be associated with
thicker and steeper corneas) may also result from dominant
mutations in FBN1. Fibronectin and IGFBP5 also bind to each
other. This binding regulates the ligand-dependent action of
IGFBP5 on insulin-like growth factors, and this has effects on
cell proliferation, differentiation, survival, and motility. IGFBP5
shows expression in the human cornea and was down regulated
in eyes with keratoconus42,43. BMP7 encodes a member of the
transforming growth factor -β superfamily that is involved in
numerous cellular functions including development, morphogen-
esis, cell proliferation, apoptosis, and ECM synthesis44. BMP7 is
key in eye development during embryogenesis, and BMP7-
knockout mice have been shown to develop anophthalmia45,46.
OFCC1 (encoding a reticular cytoplasmic protein expressed
during embryonic development) in the Medaka fish is associated
with the ojoplano (‘flat eye’) phenotype due to defective eye cup
morphogenesis47. COL5A1 and COL6A1 encode components of
type V and VI fibrillar collagens that are present in the human
cornea48. COL6A1, together with ADAMTS20, have been
reported to be associated with intraocular pressure49. COL5A1
mutations are found in classical Ehlers-Danlos Syndrome50,
which is associated with thinner and steeper corneas51. COL5A1
is also a susceptibility locus for central corneal thickness52,53.
THBS4 encodes an extracellular calcium binding protein that is
involved in cell proliferation, adhesion, and migration54. FGF9 is
involved in the neural patterning of the optic neuroepithelium55.
Genes identified as being involved in the Wnt signaling
pathway were also implicated in our analysis (SOX2, FRAT1,
FRAT2, RSPO1, FGF9; Supplementary Data 5 “canonical Wnt
signaling pathway”). Two additional Wnt signalling related genes
(ZNRF316 and WNT7B24), though not the top genes in this study,
were also identified as being associated with CC or axial length.
The Wnt signalling pathway has prominent effects on multiple
developmental events during embryogenesis56, including that of
differentiation of the anterior segment of the eye57,58, and retinal
development59,60.
Discussion
In the largest CREAM trans-ethnic GWAS meta-analysis of CC
to date (44,042 individuals with replication in 88,218 participants
from UK Biobank), we identified novel loci through single-variant
analysis, and gene-based tests. SNP-heritability was estimated at
0.267 and 0.196 in Europeans and Asians, respectively. We dis-
covered population-specific loci that existed in both European
and Asian ethnic groups, as well as the presence of a high con-
cordance of inter-population genetic effects overall. Variants were
involved in coordinating eye size (by affecting CC and AL con-
currently) whilst maintaining emmetropia (Group A). Mean-
while, other genetic variants were associated with refractive error
(Group B); the genetic effect for AL could not compensate the
effect for CC, as showing that the pleiotropic effect ratio βALβCC was
significant smaller than that of “eye size” variants. A third group
of variants was also observed that appeared independent in terms
of pleiotropic effects. Besides pathways related to the ECM, the
implicated genes were significantly enriched in pathways involved
in organism development and growth, eye development,
connective tissue cartilage and glycosylation protein activity.
Implicated genes with pleiotropic effects on refractive error were
involved in diverse pathways related to ECM and organism
development and growth.
Our data provide insights into novel genes that regulate CC
across European and Asian populations. We found trans-ethnic
replication of significant loci, and a high concordance of genetic
effects in variants with little discrepancy in allele frequency
between the two ancestry groups. Our results are robust as 90.2%
of CC-associated loci were replicated at a genome-wide sig-
nificance throughout the UK Biobank. We also confirm the
association of theMTOR loci17 with CC in Europeans, in contrast
to the lack of replication in previous Europeans studies with
much smaller sample size11,19. Although the underlying genetic
effects were largely shared between the two ancestry groups, at the
same time, population-specific loci were also observed: HDAC11/
FBLN2, ADAMTS19/CHSY3, and FGF9 in Europeans, and RBP3
and CMPK1/STIL previously reported in Asians18. In these cases,
the lead variants were monomorphic in the other non-significant
Asian or European populations, respectively, and any signals
barely seen from the flanking variants at these loci. Our data show
that the trans-ethnic meta-analysis approach yields shared and
unique variants for CC in Europeans and Asians.
We used bioinformatics tools to demonstrate the functional
connectivity between the associated genes. The newly identified
loci such as LMX1B, SOX2, NHSL1, GHSR, HMGA2, IGFBP5,
FRAT1, FRAT2, STIL, USP1, HUS1, STON2, and IGF2 are mainly
involved in organism growth and eye development. Additional
notable CC candidate genes belong to the ADAMTS family,
including ADAMTS7, ADAMTS19, and ADAMTS20 involved in
organization and function of ECM. Novel genes, such as FBN1,
BMP7, COL6A1, THBS4, FBLN2, and KAZALD1, are involved in
both ECM formation and organism development. In addition, CC-
genes associated with refractive error were involved in basement
membrane, endoplasmic reticulum lumen, collagen-containing
extracellular matrix, ossification, and osteoblast differentiation,
underlying a functional heterogeneity in genes exhibiting pleio-
tropic effects on both CC and refractive error.
Our study is the most comprehensive study on pleiotropic
effects of CC-associated genes on eye size and refractive error in
humans. Several small-size studies also have reported the effects
of ‘eye-size’ genes, such as PDGFRA11,17,19 and RBP318. Our
study confirmed previous findings. Studies in mice and chicken
also support the existence of distinctive genetic effects to deter-
mine eye sizes, for instance, (1) effects that purely govern eye size,
(2) effects restricted to specific ocular dimension (i.e. CC or AL
separately), or (3) effects that scale the size of the eye and body
simultaneously61,62. Clearly, CC-genes are involved in hetero-
geneous genetic function.
In human emmetropic eyes, CC is highly correlated with AL,
and the two are carefully scaled relative to each other63. Thus,
genetic pathways may exist to simultaneously influence AL and
CC while maintaining the emmetropic status12,61,64. In our
analyses, we have therefore compared our set of CC loci with
their respective associations with AL and refractive error. We
identified ‘eye-size’ genes (HMGA2, RSPO1, HDAC11/FBLN2,
RBP3, PDGFRA, NHSL1 and ADAMTS19/CHSY3, and INTS6)
that were associated with eye size (e.g. a larger eye with both a
flatter CC and longer AL, or vice versa), but not refractive error.
The compensatory pleiotropic effect for AL could offset CC’s
effect toward myopia or hyperopia; namely, a genetic determined
1 mm increase (or decrease) for CC accompanying a 2.92 mm
increase (or decrease) on average for AL might cancel out their
opposite effects on refractive error. This may represent a carefully
coordinated scaling of optical components to maintain the eye in
an emmetropic state as it grows. These genetic variants may
therefore control variation in eye size independent of refractive
error. Among these ‘eye-size’ genes, HMGA2 and HDAC11/
FBLN2 are likely to have pleiotropic effects on both the coordi-
nated scaling of the eye, as well as height65,66. Similarly, the
ADAMTS19 gene encodes metalloproteinases that belong to the
ADAMTS family with the members as human growth genes40.
This is consistent with the findings that height (body size) and eye
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size are genetically coordinated12,62. Among the other ‘eye-size’
genes identified, some had roles in Wnt signalling (RSPO1 and
HDAC11), platelet-derived growth factor signalling (PDGFRA),
and extracellular ligands and calcium binding (FBLN2).
In contrast to the group of ‘eye-size’ genes that do not affect
spherical equivalent, there is another group of CC-implicated
variants associated with refractive error, with little or no pleio-
tropic effect on AL (Group B). The pleiotropic ratio βALβCC was
significantly smaller than that in ‘eye-size’ variants, therefore,
without adequate compensatory effects on AL, these variants may
influence the refractive error status of the eye primarily through
CC. There is one exception at loci RP11-91P17.1. Variant
rs7000412 T allele was associated with steeper CC (that tends to
make the eye more myopic) and shorter AL (less myopic) with
overall effects towards to a hyperopic refractive error; thus this
variant influenced refractive error likely through AL. Five top loci
replicated in UK Biobank for refractive error (P < 1 × 10−7),
including CHRND/RPSS56, FBN1, CASC15, RNLS, and
KAZALD1, have also been reported in previous CREAM
GWAS13. Ten loci showed significance in replication after
accounting for multiple testing (FDR < 0.01). These genes are
actively involved in pathways of basement membrane, endo-
plasmic reticulum lumen and collagen-containing extracellular
matrix, linking to ECM and organism development, growth.
Plotnikov et al. recently also proposed a genetic link between CC
and refractive error in Europeans67. Using CC-associated SNPs in
emmetropes as instrument variables, they estimated the causal
effect of CC on refractive error to be +1.41 D (95% CI, 0.65–2.16)
less myopic refractive error per mm flatter cornea. A significant
group of CC-genes identified in our study showing association
with spherical equivalent corroborates the finding of an associa-
tion between CC and refractive error.
The remaining CC loci (Group C) were not significantly
associated with refractive error or AL. However, in a majority of
these variants, the associations with spherical equivalent,
although not statistically significant, were in the expected direc-
tion—for instance, a flatter cornea and a more hyperopic sphe-
rical equivalent, or vice versa. It is unknown whether these loci
may also have modulatory effects on other refractive components
of the eye (e.g. lens thickness or anterior chamber depth) that
may have attenuated its effect on refractive error. In addition,
some of these genes in Group 3 (FNDC3B, COL5A1, COL6A1),
together with genes in Group 2 (IGFBP5, FGF9, and CWC27/
ADAMT6) was linked to connective tissue disorder (Supple-
mentary Fig. 6) and has been associated with keratoconus29,68–71,
a disorder of corneal thinning and steepening, implying a possible
effect of CC genes regulating refractive error and keratoconus.
In summary, we have identified 47 genome-wide significant
loci for CC (of which 26 are new), through a large-scale tans-
ethnic GWAS meta-analysis. The importance of undertaking this
study in individuals of different ethnicities cannot be understated
as we identified both population-specific loci in Europeans as well
as Asians as well as loci that were common between both eth-
nicities. These findings provide insights into the underlying
genetic aetiology of eye growth and may provide pointers for us
to explore why myopia is more prevalent in Asians than Eur-
opeans. These CC loci can coordinate AL and eye-size to keep
human eyes emmetropic, and some play a role in the develop-
ment of refractive errors primarily through variations in CC.
Implicated genes were significantly enriched in a network linking
extracellular matrix organization, developmental process for body
and eye and glycosylation protein activities. Elucidating and
characterising the heterogeneity of such genes that regulate the
optical component dimensions of the eye may enable a better
understanding of the biology of both emmetropia and ametropia
in humans.
Methods
Study populations. The discovery cohorts included 29,580 individuals with Eur-
opean ancestry from 18 studies, and 14,464 with Asian ancestry from 10 studies.
General methods, demographics, and phenotyping of the study cohorts have
previously been extensively described, and are provided in brief in Supplementary
Table 1 and Supplementary Notes. In the replication phase, 88,218 participants of
European ancestry from the UK Biobank who had measurements for CC were
included in the replication stage, as well as 95,505 participants of European
ancestry (from the UK Biobank) with phenotype information for refractive error3.
Written informed consent was obtained from all participants in accordance with
the Declaration of Helsinki. All studies were performed with the approval of their
local Human Research and Ethics Committee.
Phenotype measurements. All participating CREAM cohorts used similar pro-
tocols for the collection of keratometry and other ocular biometric measurements.
The protocols have been described in detail elsewhere14,16,59. In brief, CC radii in
the horizontal and vertical meridians were measured using an autokeratometer.
The means (in millimetre) of CC from the individuals’ two eyes were used for
analysis, while the means of the readings from one eye were used when the readings
from the other eye were unavailable. Participants were excluded if they had corneal
scars, keratoconus, prior refractive or cataract surgery, or other intraocular pro-
cedures that could alter CC. For the UK Biobank, participants were excluded from
the analyses if they had an eye disorder that may have altered their refractive error
or CC (see Supplementary Notes).
Genotyping and imputation. The CREAM study samples were genotyped on
either Illumina or Affymetrix platforms. Genotypes were imputed using the 1000 G
Genomes Project reference panel (Phase I version 3, March 2012 release). SNPs
with low imputation quality were filtered using metrics specific to the imputation
method and thresholds used in previous GWAS analyses. The Markov Chain
Haplotyping software, IMPUTE72,73, or MACH74 were adopted for imputation.
A detailed description regarding genotyping platforms and imputation procedures
have been outlined (Supplementary Table 2). Stringent quality control of genotype
data was applied in each cohort from CREAM. Samples with low call rates (<95%)
or with gender discrepancies were excluded. Cryptically related samples and out-
liers in population structure from principal component analyses were also exclu-
ded. SNPs flagged with missingness >5%, gross departure from Hardy-Weinberg
equilibrium (P < 10−6), and minor allele frequency (MAF) < 1% were removed
from further analyses. Poorly imputed markers (IMPUTE info < 0.5 or minimac
Rsq < 0.5) were excluded. UK Biobank genotyping arrays were imputed to the HRC
reference panel and a combined 1000 Genomes Project –UK10K reference panel
using IMPUTE475. Data quality control (QC) was described in the Supplementary
Notes.
Statistical analyses and meta-analyses. We assumed an additive genetic model
where the dosage of each SNP was a continuous variable ranging from 0 to 2 for the
effect allele. For each study, an additive allele-dosage regression model, adjusted for
both age and sex at each genotyped or imputed SNP, was conducted to determine
its association with CC represented as a quantitative trait. An additional adjust-
ment for up to the first five principal components was carried out according to the
population substructure in each individual study. For studies that included children
and adolescent participants, GWAS analyses were conducted separately by age
groups (age ≥ 25 vs. age < 25), as for previous GWAS analyses for corneal astig-
matism76. Sample outliers with CC values exceeding six standard deviations from
the mean were excluded at the study level. The per-SNP meta-analyses were per-
formed in METAL software (https://genome.sph.umich.edu/wiki/METAL) with a
weighted inverse-variance approach77. A Cochran’s Q test was used to assess
heterogeneity across studies78.
Locus identification and genetic variants annotation. The independent signal
from the meta-analysis was determined using LD-clumping procedure in PLINK
(https://www.cog-genomics.org/plink2). The index variant was identified (P < 5 ×
10−8) in each clump, which was formed for variants with P < 1 × 10−5 that were in
LD (r2 > 0.1) and within 500 kb of the index variant. The same variant were
assigned to no more than one clump. The LD structure was estimated from the
European panel in the 1000 Genome Project as the reference population, or Asian
panel for meta-analysis summary statistics in Asians. A locus was identified by an
index variant with the regions flanking 250 kb on both sides. For those with
multiple signals in one locus (500 kb region) or an overlapping of multiple loci
identified from the PLINK clumping procedure, conditional analysis was further
performed to confirm the independent signals using GCTA-COJO79. The LD
structure was estimated in the same manner as for LD-clumping procedure in
PLINK. The regional plot was drawn for each identified locus from the combined
meta-analysis (Supplementary Fig. 4) using LocusZoom (http://locuszoom.org/).
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The coordinates and variant identifiers are reported on the NCBI B37 (hg19)
genome build, and annotated using UCSC Genome Browser80. We identified
variants within each of the LD blocks (r2 ≥ 0.6) in European and Asian populations
of the 1000 Genomes Project (100 Kb flanking the top SNP at each locus) to apply
functional annotations of transcription regulation using HaploReg81 (https://pubs.
broadinstitute.org/mammals/haploreg/haploreg_v3.php) and Encyclopedia of
DNA Elements (ENCODE)82 data.
Replication in UK Biobank participants. The UK Biobank reported the maximum
and minimum corneal power in each eye. After taking the mean of replicate
readings, the corneal power in each eye was calculated as the mean of the max-
imum and minimum values. Corneal power was converted to corneal radius of
curvature using the equation CC= (337.5/corneal power). For the genetic analysis
of CC in all available participants, we took the average CC of the two eyes as the
phenotype. A total of 88,218 individuals were included in the analysis for CC in all
available participants. Analyses were performed using BOLT v2.322. Variant gen-
otype, age, sex, genotyping array (coded as 0 or 1 for the UK BiLEVE or UK
Biobank Axiom, respectively) and the first 10 PCs were included as covariates.
BOLT uses a mixed model to account for relatedness (kinship) between individuals.
Gene-based tests and pathway analyses. Gene-based testing was conducted
using the VEGAS software25,26 (https://vegas2.qimrberghofer.edu.au/) on the
results of separate meta-analyses of GWAS in European and Asian ancestries.
Gene-based p-values from different populations were combined by Fisher’s
method. For samples of European descent, we used the European panel in the 1000
Genome Project as the reference population to estimate patterns of LD. For the
Asian ancestry groups, we used the combined 1000 Genome Project Asian samples
as the reference population to approximate LD patterns. To include gene regulatory
regions, SNPs were included if they fell within 50 kb of the transcription start site
of genes.
VEGAS-Pathway analysis25,26,83 was carried out with pre-specified pathways
from Gene Ontology84, MSigDB85 (containing canonical pathways and gene-sets
from BIOCARTA, REACTOME, KEGG databases), PANTHER86, and pathway
commons databases87. We filtered these gene-sets to include only pathways with
10–1000 genes, yielding 9734 pathways. Empirical VEGAS-Pathway p values for
each pathway were computed by comparing the summed χ2 test statistics from real
data with those generated in 500,000 simulations where the relevant number
(according to the size of the pathway) of randomly drawn χ2 test statistics was
summed. To ensure that clusters of genes did not adversely affect results within
each pathway, gene-sets were pruned such that each gene was >500 kb away from
all other genes in the same pathway. We performed meta-analysis on the two sets
of pathway p-values from Asian and European samples by Fisher’s method.
We investigated functional annotation of the top identified genes using g:
Profiler (https://biit.cs.ut.ee/gprofiler/gost). For g:Profiler, we used “g:GOST”
function to perform pathway analysis on identified CC-associated genes. Pre-
specified pathways include Gene Ontology, pathways from KEGG, Reactome,
WikiPathways and protein complexes from CORUM88. The significant pathway
was claimed at the adjusted p-value < 0.05 after correction for multiple testing.
To investigate the connection between the enriched gene-sets, we mapped these
gene-sets into network functional enrichment map analysis27. We visualize the
network enrichment in Cytoscape software v3.7.1 (https://cytoscape.org/)28. Highly
similar gene-sets were placed close together with the interconnectivity among gene-
sets drawn by line (edge; similarity coefficient > 0.375).
Association of corneal curvature loci with axial length and spherical equiva-
lent. For all identified CC-associated variants, we assessed their association with
refractive error in European participants of UK Biobank (N= 95,505). We further
assessed the association of CC-associated variants with AL using a subset of
CREAM cohorts (N= 10,851; Supplementary Table 5). False discovery rates (FDR)
from the Benjamini-Hochberg procedure were set at 1% as a threshold of statistical
significance23. We categorized CC variants into three groups: (A) variants were
associated with AL, but not spherical equivalent; (B) variants were associated with
spherical equivalent; and (C) variants were not associated with spherical
equivalent or AL.
Pleiotropic effect ratio βALβCC at each variant was calculated to quantify relevant
genetic effects on AL versus effects on CC and the variance was calculated using
Delta method. To estimate the pleiotropic effect ratio for variants in each group, we
performed meta-analyses in METAL software (https://genome.sph.umich.edu/
wiki/METAL) with a weighted inverse-variance approach77. A Cochran’s Q test
was used to assess heterogeneity across variants78. Z-statistics were used to test the
significant difference of the pleiotropic ratio βALβCC .
SNP-heritability estimation. We applied the LD score method22 (https://github.
com/bulik/ldsc) using GWAS summary statistics to estimate SNP-h2. After mer-
ging SNPs with the HapMap3 Asian samples, we had a total of 1,174,487 and
1,085,659 SNPs for the LD score regression analyses for the European and Asian
populations, respectively. The LD score matrix was estimated from the 1000
Genomes Project Asian reference panel, or European reference panel separately,
with a 1 cM sliding window. We calculated the heritability using the software Idsc
v1.0.0. The resulting regression slope was multiplied by the number of effective
SNPs in the reference panel from the 1000 Genomes Project data22.
Gene expression in human ocular tissues. To assess gene expression in human
tissues, we examined the Ocular Tissue Database (OTDB) (https://genome.uiowa.
edu/otdb/) and the EyeSAGE database89,90 (http://people.duke.edu/~bowes007/
EyeSAGE.htm). The estimated gene and exome level abundances are available
online. Normalization of gene expression used the PLIER method with GC-
background correction89. Relationships between genotype and cis regulation of gene
expression levels were assessed using expression quantitative trait locus (eQTL)
associations obtained from GTEx Portal database91 (https://gtexportal.org/home/).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The summary statistics of the meta-analysis combining studies in CREAM are included
in Supplementary Data 8. To protect the privacy of the participants in our cohorts, the
datasets generated during and/or analysed during the current study are available from the
corresponding authors on reasonable request.
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